Corbus Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:CRBP

Comments

Corbus Pharmaceuticals Holdings Inc Earnings Estimates

CRBPNASDAQ

Trade with Public

$9.80

-0.52-5.04%

At close: Apr 10, 5:00 PM EST

$9.81

0.010.10%

After Hours: 4:16 AM EST

Overview NewsEarningsOptions Analyst Ratings Insider Trades Short Interest Stock Report

Corbus Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:CRBP

Corbus Pharmaceuticals (CRBP) is scheduled to report Q1 earnings on May 5, 2026. Analysts estimate EPS of $-1.23 and quarterly revenue of N/A.

In the most recent quarter (Q4), Corbus Pharmaceuticals reported EPS of $-1.25, beating estimates of $-1.66 by 0.25%. Revenue came in at $0.00, missing the estimate of $1.11M by 1.00%.

Over the last 4 quarters, Corbus Pharmaceuticals has averaged an EPS surprise of 0.16% and a revenue surprise of 1.00%.

Earnings Date

May 5

EPS Estimate

$-1.230

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–

Corbus Pharmaceuticals Earnings History

Analyze the earnings history of Corbus Pharmaceuticals using advanced sorting and filters.

Loading calendar...

Corbus Pharmaceuticals (CRBP) Earnings Per Share

The chart below shows Corbus Pharmaceuticals's reported EPS compared to analyst estimates over recent quarters.

Corbus Pharmaceuticals (CRBP) Revenue

The chart below shows Corbus Pharmaceuticals's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Corbus Pharmaceuticals (NASDAQ:CRBP) reporting earnings?

Corbus Pharmaceuticals (CRBP) is scheduled to report earnings on May 5, 2026. The last reported earnings were for reported on March 9, 2026 for Q4.

What were the latest earnings per share (EPS) for Corbus Pharmaceuticals (NASDAQ:CRBP)?

The Actual EPS was $-1.25, which beat the estimate of $-1.66.

What were Corbus Pharmaceuticals’s (NASDAQ:CRBP) revenues?

The Actual Revenue was $0.00, which missed the estimate of $1.11M.

People Also Watch

Molecular Partners AG

NASDAQ:MOLN

$4.05

No data available

Atrium Therapeutics Inc

NASDAQ:RNA

$12.71

ProQR Therapeutics NV

Burning Rock Biotech Ltd

NASDAQ:BNR

$16.40

3.50%

Elicio Therapeutics Inc

NASDAQ:ELTX

$10.00

-1.48%

Whitehawk Therapeutics Inc

NASDAQ:WHWK

$3.39

Corbus Pharmaceuticals Earnings Estimates, EPS & Revenue | NASDAQ:CRBP

Corbus Pharmaceuticals (CRBP) is scheduled to report Q1 earnings on May 5, 2026. Analysts estimate EPS of $-1.23 and quarterly revenue of N/A.

In the most recent quarter (Q4), Corbus Pharmaceuticals reported EPS of $-1.25, beating estimates of $-1.66 by 0.25%. Revenue came in at $0.00, missing the estimate of $1.11M by 1.00%.

Over the last 4 quarters, Corbus Pharmaceuticals has averaged an EPS surprise of 0.16% and a revenue surprise of 1.00%.

Earnings Date

May 5

EPS Estimate

$-1.230

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–